JP4025548B2 - 多薬剤耐性菌株に対して有用な抗感染症薬 - Google Patents

多薬剤耐性菌株に対して有用な抗感染症薬 Download PDF

Info

Publication number
JP4025548B2
JP4025548B2 JP2001562429A JP2001562429A JP4025548B2 JP 4025548 B2 JP4025548 B2 JP 4025548B2 JP 2001562429 A JP2001562429 A JP 2001562429A JP 2001562429 A JP2001562429 A JP 2001562429A JP 4025548 B2 JP4025548 B2 JP 4025548B2
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
body weight
administration
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2001562429A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004501865A (ja
JP2004501865A5 (https=
Inventor
マー，チエンクン
ネモト，ピーター・エイ
チヤン，ソウミン
ヨン，ホン
オア，ヤツト・サン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of JP2004501865A publication Critical patent/JP2004501865A/ja
Publication of JP2004501865A5 publication Critical patent/JP2004501865A5/ja
Application granted granted Critical
Publication of JP4025548B2 publication Critical patent/JP4025548B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2001562429A 2000-02-24 2001-02-23 多薬剤耐性菌株に対して有用な抗感染症薬 Expired - Fee Related JP4025548B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51223400A 2000-02-24 2000-02-24
PCT/US2001/006006 WO2001063539A2 (en) 2000-02-24 2001-02-23 Anti-infective agents useful against multidrug-resistant strains of bacteria

Publications (3)

Publication Number Publication Date
JP2004501865A JP2004501865A (ja) 2004-01-22
JP2004501865A5 JP2004501865A5 (https=) 2005-02-03
JP4025548B2 true JP4025548B2 (ja) 2007-12-19

Family

ID=24038243

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001562429A Expired - Fee Related JP4025548B2 (ja) 2000-02-24 2001-02-23 多薬剤耐性菌株に対して有用な抗感染症薬

Country Status (9)

Country Link
EP (1) EP1259923B1 (https=)
JP (1) JP4025548B2 (https=)
AT (1) ATE312839T1 (https=)
CA (1) CA2398848C (https=)
DE (1) DE60115851T2 (https=)
DK (1) DK1259923T3 (https=)
ES (1) ES2254389T3 (https=)
MX (1) MXPA02008274A (https=)
WO (1) WO2001063539A2 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0127349D0 (en) 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides
WO2003090761A1 (en) * 2002-04-25 2003-11-06 Abbott Laboratories 9-oxime macrolide antibacterials
GB0225384D0 (en) 2002-10-31 2002-12-11 Glaxo Group Ltd Novel compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8506380D0 (en) * 1985-03-12 1985-04-11 Beecham Group Plc Chemical compounds
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of erythromycin derivatives
CA2253338C (en) * 1996-05-07 2007-05-08 Abbott Laboratories 6-o-substituted erythromycins and method for making them
AR023264A1 (es) * 1999-04-08 2002-09-04 Hokuriku Pharmaceutical Derivados de eritromicina

Also Published As

Publication number Publication date
DK1259923T3 (da) 2006-05-01
JP2004501865A (ja) 2004-01-22
ES2254389T3 (es) 2006-06-16
CA2398848A1 (en) 2001-08-30
DE60115851D1 (de) 2006-01-19
DE60115851T2 (de) 2006-08-10
WO2001063539A2 (en) 2001-08-30
ATE312839T1 (de) 2005-12-15
EP1259923B1 (en) 2005-12-14
MXPA02008274A (es) 2003-01-28
EP1259923A2 (en) 2002-11-27
CA2398848C (en) 2007-09-25
WO2001063539A8 (en) 2002-09-19
WO2001063539A3 (en) 2003-03-06

Similar Documents

Publication Publication Date Title
CA2253338C (en) 6-o-substituted erythromycins and method for making them
US5922683A (en) Multicyclic erythromycin derivatives
US5866549A (en) 6-O-substituted ketolides having antibacterial activity
US6046171A (en) 6,11-bridged erythromycin derivatives
US6147197A (en) 6-O-substituted erythromycin ketolides having antibacterial activity
CA2451391A1 (en) C12 modified erythromycin macrolides and ketolides having antibacterial activity
EP1015467B1 (en) 6,9-bridged erythromycin derivatives
EP1027362B1 (en) 2-halo-6-o-substituted ketolide derivatives
EP1027361B1 (en) 6,11-bridged erythromycin derivatives
EP1025114B1 (en) 3'-n-modified 6-o-substituted erythromycin ketolide derivatives having antibacterial activity
US6034069A (en) 3-'N-modified 6-O-substituted erythromycin ketolide derivatives having antibacterial activity
US6946446B2 (en) Anti-infective agents useful against multidrug-resistant strains of bacteria
EP1007530A1 (en) 6-o-substituted erythromycin compounds and method for making same
JP4025548B2 (ja) 多薬剤耐性菌株に対して有用な抗感染症薬
EP1181300B1 (en) 6-o-carbamate ketolide derivatives
US6727229B2 (en) 11,12-substituted lactone ketolide derivatives having antibacterial activity
JP2003501439A5 (https=)
EP0984975B1 (en) Multicyclic erythromycin derivatives
US6764996B1 (en) 9a-azalides with antibacterial activity
HK1031383B (en) 2-halo-6-o-subsituted ketolide derivatives
KR20000010800A (ko) 6-o-치환된 에리트로마이신 화합물 및 이의 제조방법
MXPA00002216A (en) 3-descladinose 6-o-substituded erythromycin derivatives

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20060620

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20060919

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20060926

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20061220

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20070220

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20070515

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20070522

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070817

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20070918

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20071005

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101012

Year of fee payment: 3

LAPS Cancellation because of no payment of annual fees